pT1 clear cell renal cell carcinoma - A study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival

被引:22
作者
Cheville, JC
Zincke, H
Lohse, CM
Sebo, TJ
Riehle, D
Weaver, AL
Blute, ML
机构
[1] Mayo Clin & Mayo Fdn, Dept Pathol & Lab Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
clear cell renal cell carcinoma; MIB-1; proliferation; survival;
D O I
10.1002/cncr.10433
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The majority of patients with pT1 clear cell renal cell carcinoma (RCC) are cured with nephrectomy. However, a few patients will die of RCC. In several Studies, MIB-1 proliferative activity was identified as an independent predictor of survival in patients with RCC. The objective of the current study was to examine MIB-1 proliferative activity in a large series of patients with pT1 clear cell RCC who were treated uniformly with radical nephrectomy, and to examine the association between proliferative activity and cancer specific survival in a multivariate model incorporating tumor size, nuclear grade, and tumor necrosis. METHODS. Patients with solitary pT1 clear cell RCC Who underwent radical nephrectomy between 1970-1997 were eligible for the current study. For each of the 40 patients who died of RCC, a stratified random sample of at least 3 year-matched patients who still were alive or had died of other causes at the time of last follow-up was selected. Patient age at nephrectomy, patient gender, tumor size, nuclear grade, and tumor necrosis were evaluated, and the MIB-1 proliferative activity was assessed using digital image analysis. Univariate and multivariate Cox proportional hazards models were fit to assess the features associated with cancer specific survival, The associations between MIB-1 proliferative activity and pathologic features were assessed using the Wilcoxon rank sum test. RESULTS. The mean MIB-1 value for those patients who died of clear cell RCC was 6.5% compared with 3.6% for those patients who died of other causes or were still alive at the time of last follow-up. Patients whose tumor had an MIB-1 proliferative activity greater than or equal to 5.0% were more than twice as likely to die of RCC than patients whose tumors had a MIB-1 activity < 5% (P = 0.02). However, after adjusting for tumor size, nuclear grade, and necrosis, MIB-1 proliferative activity was not found to be associated significantly with cancer specific survival. There was a significant association between MIB-1 proliferative activity and tumor size, nuclear grade, and necrosis. CONCLUSIONS. After adjusting for tumor size, nuclear grade, and necrosis, MIB-1 proliferative activity was not found to be an independent predictor of outcome in patients with pT1 clear cell RCC who were treated with radical nephrectomy. There was a significant association between MIB-1 and other well established pathologic prognostic features of pT1 clear cell RCC. (C) 2001 American Cancer Society.
引用
收藏
页码:2180 / 2184
页数:5
相关论文
共 11 条
[1]   Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases [J].
Amin, MB ;
Corless, CL ;
Renshaw, AA ;
Tickoo, SK ;
Kubus, J ;
Schultz, DS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (06) :621-635
[2]   Stage pT1 conventional (clear cell) renal cell carcinoma: Pathological features associated with cancer specific survival [J].
Cheville, JC ;
Blute, ML ;
Zincke, H ;
Lohse, CM ;
Weaver, AL .
JOURNAL OF UROLOGY, 2001, 166 (02) :453-456
[3]   Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases [J].
Delahunt, B ;
Eble, JN ;
McCredie, MRE ;
Bethwaite, PB ;
Stewart, JH ;
Bilous, AM .
HUMAN PATHOLOGY, 2001, 32 (06) :590-595
[4]   PROGNOSTIC-SIGNIFICANCE OF KI-67 IMMUNOSTAINING IN NONMETASTATIC RENAL-CELL CARCINOMA [J].
DERIESE, WTW ;
CRABTREE, WN ;
ALLHOFF, EP ;
WERNER, M ;
LIEDKE, S ;
LENIS, G ;
ATZPODIEN, J ;
KIRCHNER, H .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1804-1808
[5]   THE PROLIFERATION-ASSOCIATED KI-67 PROTEIN - DEFINITION IN MOLECULAR TERMS [J].
DUCHROW, M ;
GERDES, J ;
SCHLUTER, C .
CELL PROLIFERATION, 1994, 27 (05) :235-242
[6]   Proliferating cell nuclear antigen and MIB-1 - An alternative to classic prognostic indicators in renal cell carcinomas? [J].
Haitel, A ;
Wiener, HG ;
Migschitz, B ;
Marberger, M ;
Susani, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (02) :229-235
[7]  
Jochum W, 1996, CANCER, V77, P514
[8]  
LAU W, UNPUB STAGE PT1 RENA
[9]  
PRENTICE RL, 1986, BIOMETRIKA, V73, P1
[10]  
Tannapfel A, 1997, ANTICANCER RES, V17, P1155